German Court Voids AstraZeneca's Seroquel XR Patent
Germany's federal patent court has invalidated an AstraZeneca AB patent covering Seroquel XR, the extended release version of its blockbuster anti-psychotic drug, the company said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article